Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
Authors:
Open Access
- 3 July 2024
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2372884
Abstract
To fully understand the safety of DTaP-IPV/Hib vaccination, we evaluated the differences between DTaP-IPV/Hib co-administration and separate administration of the DTaP, IPV and Hib vaccines (DTaP+IPV+Hib) based on adverse events following immunization (AEFI). All AEFI reported in Hebei Province, China, between 2020 and 2022 were included in this study. The risk difference (RD%), relative risk (RR), and Chi-square value were used to compare the differences in reported rates of AEFI between the DTaP-IPV/Hib and DTaP+IPV+Hib groups. From 2020 to 2022, 130 AEFI cases were reported in Hebei Province after DTaP-IPV/Hib vaccination, corresponding to an AEFI reported rate of 66.9/million doses, which was significantly lower than that for DTaP+IPV+Hib (9836 AEFI with a reported rate of 637.8/million doses). The overall reported rate of non-severe AEFI for DTaP+IPV+Hib vaccines was 9.5 times that of DTaP-IPV/Hib vaccination [95% confidence interval (CI): 8.0, 11.3]. Meanwhile, the reported rate of AEFI among infants aged 0-1 y was 9.8 times higher for DTaP+IPV+Hib than for DTaP-IPV/Hib (95% CI: 8.2, 11.7). DTaP+IPV+Hib vaccination also resulted in higher risks of high fever, localized redness and swelling, localized induration, and allergic rash compared with DTaP-IPV/Hib vaccination. The risk of AEFI, which were mostly mild reaction, was higher after vaccination with DTaP+IPV+Hib than after DTaP-IPV/Hib vaccination.Keywords
Funding Information
- Hebei Provincial Health and Family Planning Commission
This publication has 18 references indexed in Scilit:
- Childhood Immunization Schedule for National Immunization Program Vaccines — China (Version 2021)China CDC Weekly, 2021
- Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature ReviewVaccines, 2019
- A systematic review of factors affecting vaccine uptake in young childrenVaccine, 2017
- The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populationsVaccine, 2017
- Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to ChinaVaccine, 2013
- Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type bJAMA, 2012
- Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of ChinaVaccine, 2011
- [Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China].2011
- Sudden Unexpected Deaths and Vaccinations during the First Two Years of Life in Italy: A Case Series StudyPLOS ONE, 2011
- Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age.2003